
Friulchem — Investor Relations & Filings
Friulchem is a Contract Development and Manufacturing Organization (CDMO) dedicated to the Animal Health sector. The company provides integrated services that cover the research, development, and production of veterinary products. Its manufacturing capabilities include micronization, granulation, mixing, spray drying, and packaging. Friulchem produces a range of items, including pharmaceuticals, food supplements, complementary feeds, and premixes for both livestock and companion animals. The company utilizes proprietary drug delivery technologies to develop customized formulations. A key product is Fc-Cubes®, a highly palatable chewable tablet for pets, which is part of its Suppleo brand of complementary foods.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Autorizzazione per la commercializzazione in Sudafrica di un antibiotico ad uso umano e avvia un accordo pluriennale per la distribuzione in esclusiva | 2019-10-15 | Italian | |
| Internal dealing | 2019-10-11 | Italian | |
| Friulchem prosegue nel percorso di internazionalizzazione con la costituzione di Friulchem usa inc. | 2019-09-27 | Italian | |
| Commento AD alla semestrale 2019 | 2019-09-26 | Italian | |
| Approvata la relazione semestrale al 30 giugno 2019 | 2019-09-26 | Italian | |
| Friulchem Azionisti Significativi | 2019-07-29 | Italian |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2019
9 filings
| |||||
| 2249388 | Autorizzazione per la commercializzazione in Sudafrica di un antibiotico ad uso umano e avvia un accordo pluriennale per la distribuzione in esclusiva | 2019-10-15 | Italian | ||
| 2249398 | Internal dealing | 2019-10-11 | Italian | ||
| 2249581 | Friulchem prosegue nel percorso di internazionalizzazione con la costituzione di Friulchem usa inc. | 2019-09-27 | Italian | ||
| 2249604 | Commento AD alla semestrale 2019 | 2019-09-26 | Italian | ||
| 2249625 | Approvata la relazione semestrale al 30 giugno 2019 | 2019-09-26 | Italian | ||
| 2250284 | Friulchem Azionisti Significativi | 2019-07-29 | Italian | ||
| 2250321 | Calendario Finanziario 2019 | 2019-07-25 | Italian | ||
| 2250358 | NOTIFICATO A CONSOB IL KID RELATIVO AI “WARRANT FRIULCHEM 2019-2022” | 2019-07-23 | Italian | ||
| 2250368 | FRIULCHEM AMMESSA ALLE NEGOZIAZIONI SUL MERCATO AIM ITALIA | 2019-07-23 | Italian | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Friulchem, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Friulchem via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4187/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4187 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4187 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4187 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4187}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Friulchem (id: 4187)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.